Literature DB >> 216002

Compartmentalization of cyclic AMP-dependent protein kinases in human erythrocytes.

G Dreyfuss, K J Schwartz, E R Blout.   

Abstract

The human erythrocyte contains two types of cyclic AMP-dependent protein kinase. The membrane-associated protein kinase holoenzyme can be released intact by hypotonic treatment at alkaline pH. Chromatography on DEAE-cellulose and molecular weight determinations demonstrate that this enzyme is a type I cyclic AMP-dependent protein kinase, while the predominant cyclic AMP-dependent protein kinase found in the cytoplasm is type II. The catalytic subunits of the two types of kinase found in the erythrocyte are identical, but the regulatory subunits, which distinguish the two types of kinase, determine their localization within the cell. It is proposed that the regulatory subunit of the type I enzyme, in addition to binding the catalytic subunit, interacts specifically with one or more membrane proteins and that this interaction may serve to position the kinase in preferential proximity to protein substrates.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 216002      PMCID: PMC393089          DOI: 10.1073/pnas.75.12.5926

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Specific regulation by steroid hormones of the amount of type I cyclic AMP-dependent protein kinase holoenzyme.

Authors:  D J Fuller; C V Byus; D H Russell
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

2.  Cyclic AMP-dependent protein kinases from normal and SV40-transformed 3T3 cells.

Authors:  A J Gharrett; A M Malkinson; J R Sheppard
Journal:  Nature       Date:  1976-12-16       Impact factor: 49.962

3.  Purification and characterization of an adenosine cyclic 3':5' monophosphate-dependent protein kinase from human erythrocyte membrane.

Authors:  P Boivin; C Galand
Journal:  Biochem Biophys Res Commun       Date:  1978-03-30       Impact factor: 3.575

Review 4.  Protein kinases.

Authors:  E G Krebs
Journal:  Curr Top Cell Regul       Date:  1972

5.  Phosphorylation of endogenous substrates by erythrocyte membrane protein kinases. II. Cyclic adenosine monophosphate-stimulated reactions.

Authors:  G Fairbanks; J Avruch
Journal:  Biochemistry       Date:  1974-12-31       Impact factor: 3.162

6.  Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes.

Authors:  T L Steck; J A Kant
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

7.  Purification and characterization of catalytic subunit of skeletal muscle adenosine 3':5'-monophosphate-dependent protein kinase.

Authors:  P J Bechtel; J A Beavo; E G Krebs
Journal:  J Biol Chem       Date:  1977-04-25       Impact factor: 5.157

8.  Characterization and regulation of heart adenosine 3':5'-monophosphate-dependent protein kinase isozymes.

Authors:  J D Corbin; S L Keely
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

9.  Identification, characterization, and quantitative measurement of cyclic AMP receptor proteins in cytosol of various tissues using a photoaffinity ligand.

Authors:  U Walter; I Uno; A Y Liu; P Greengard
Journal:  J Biol Chem       Date:  1977-09-25       Impact factor: 5.157

10.  Purification and characterization of the catalytic subunit of adenosine 3':5'-cyclic monophosphate-dependent protein kinase from bovine liver.

Authors:  P H Sugden; L A Holladay; E M Reimann; J D Corbin
Journal:  Biochem J       Date:  1976-11       Impact factor: 3.857

View more
  12 in total

1.  Protein kinases A and C regulate receptor-mediated increases in cAMP in rabbit erythrocytes.

Authors:  Shaquria P Adderley; Meera Sridharan; Elizabeth A Bowles; Alan H Stephenson; Mary L Ellsworth; Randy S Sprague
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-11       Impact factor: 4.733

2.  Characterization of the protein kinase activities of human platelet supernatant and particulate fractions.

Authors:  S E Salama; R J Haslam
Journal:  Biochem J       Date:  1984-03-01       Impact factor: 3.857

3.  Characterization and comparison of the soluble and membrane-bound cyclic AMP-dependent protein kinase from swine kidney.

Authors:  K Muniyappa; F H Leibach; J Mendicino
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

4.  Inhibition of ATP release from erythrocytes: a role for EPACs and PKC.

Authors:  Shaquria P Adderley; Meera Sridharan; Elizabeth A Bowles; Alan H Stephenson; Randy S Sprague; Mary L Ellsworth
Journal:  Microcirculation       Date:  2011-02       Impact factor: 2.628

5.  Deficiency of cyclic AMP-dependent protein kinases in human psoriasis.

Authors:  D E Brion; F Raynaud; A Plet; P Laurent; B Leduc; W Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

6.  Interaction of Ca2+ and protein phosphorylation in the rabbit platelet release reaction.

Authors:  R M Lyons; J O Shaw
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

7.  Changes in cyclic AMP-dependent protein kinases during inhibition of mastocytoma cell growth by dibutyryl cyclic AMP.

Authors:  J Evans; J Smart; P Airey; R Ralph
Journal:  Mol Cell Biochem       Date:  1982-04-02       Impact factor: 3.396

8.  Defining erythrocyte internal labeling by phosphorylation.

Authors:  J A Babitch; M R Macha; P A Kiener
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

9.  Regulation of ornithine decarboxylase activity by corticotropin in adrenocortical tumor cell clones: roles of cyclic AMP and cyclic AMP-dependent protein kinase.

Authors:  J E Kudlow; P A Rae; N S Gutmann; B P Schimmer; G N Burrow
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

10.  The mechanism of transmembrane delta muH+ generation in mitochondria by cytochrome c oxidase.

Authors:  M Lorusso; F Capuano; D Boffoli; R Stefanelli; S Papa
Journal:  Biochem J       Date:  1979-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.